Chandigarh: Haryana Health Minister Arti Singh Rao said the State Government is fully committed to ensuring the availability of safe and quality medicines to citizens and is taking sustained action in this regard. She said that the Food and Drugs Administration (FDA) Department has been directed to take stringent action against those involved in the manufacture and sale of counterfeit medicines.
A spokesperson of the Food and Drugs Administration Department said that, acting on the directions of the Health Minister, the Drug Wing conducted an extensive inspection drive from April 1 to September 30, 2026. During this period, a total of 13,590 drug sale units and 423 manufacturing units were inspected. Following the detection of regulatory violations and irregularities, 966 drug sale licences and 12 manufacturing/blood centre licences were suspended. In addition, 15 licences were cancelled completely, while five were partially cancelled.
The spokesperson said that, as part of efforts to strengthen quality control, 2,389 samples were collected during the period, of which 2,189 have been tested. Of these, 11 samples were found to be substandard.
The spokesperson further said that the Department initiated prosecution in 64 cases against those found violating the prescribed regulations. Meanwhile, 15 cases pending before various courts were disposed of, resulting in convictions in eight cases and acquittals in seven. At present, 462 cases remain pending before the courts.
